A foundational, provider-supervised start to dual-pathway GLP-1/GIP therapy. Tier 1 is designed for first-time or re-starting patients who need a gentle, steady on-ramp to reduce appetite, improve post-meal glucose, and build early momentum without aggressive dose jumps. Includes eligibility screening, dosing plan, and scheduled check-ins to review progress and side-effect mitigation.
Dosage: 16.6 mg/ml · Volume: 2 ml
Best for: first 4–6 weeks or sensitive responders
Includes: provider oversight + messaging support
Adjustments made at follow-up as needed